MoneyWorks4Me

Cadila Healthcare informs about press release

04 Jun 2016 Evaluate

Cadila Healthcare has informed about a Press Release dated June 04, 2016 titled ‘Zydus receives approval from USFDA to initiate Phase 2 clinical trials of Saroglitazar in patients with Non-Alcoholic Steatohepatitis (NASH) of the liver in USA’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1754.00
Dr. Reddys Labs. 1236.70
Cipla 1330.20
Lupin 1949.00
Zydus Lifesciences 1121.85
View more..